Literature DB >> 20207160

CRP-induced levels of oxidative stress are higher in brain than aortic endothelial cells.

Dorothea Closhen1, Bianca Bender, Heiko J Luhmann, Christoph R W Kuhlmann.   

Abstract

C-reactive protein (CRP) has been demonstrated to induce blood-brain barrier disruption (BBB) involving NAD(P)H-oxidase dependent oxidative stress. It is unclear why CRP affects the BBB and not other vascular beds following stroke. Therefore we examined CRP receptor and NAD(P)H-oxidase expression levels in bovine brain- (BEC) and aortic endothelial cells. Dichlorodihydrofluorescein measurements revealed significantly higher CRP-induced reactive oxygen species (ROS) levels in BEC. Protein expression of the CRP-receptors CD16, CD32 and of the NAD(P)H-oxidase subunit p22phox were also significantly higher in BEC. In conclusion BEC show a higher vulnerability to CRP due to increased levels of CRP receptors and the NAD(P)H-oxidase. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207160     DOI: 10.1016/j.cyto.2010.02.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  16 in total

Review 1.  Early life stress perturbs the function of microglia in the developing rodent brain: New insights and future challenges.

Authors:  Frances K Johnson; Arie Kaffman
Journal:  Brain Behav Immun       Date:  2017-06-15       Impact factor: 7.217

2.  Hypoxia induces angiogenic factors in brain microvascular endothelial cells.

Authors:  J Luo; J Martinez; X Yin; A Sanchez; D Tripathy; P Grammas
Journal:  Microvasc Res       Date:  2011-11-10       Impact factor: 3.514

3.  Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.

Authors:  Hossein Sanjari Moghaddam; Zahra Valitabar; Amir Ashraf-Ganjouei; Mahtab Mojtahed Zadeh; Farzaneh Ghazi Sherbaf; Mohammad Hadi Aarabi
Journal:  Neuromolecular Med       Date:  2018-07-06       Impact factor: 3.843

4.  Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.

Authors:  Christian Lunetta; Andrea Lizio; Eleonora Maestri; Valeria Ada Sansone; Gabriele Mora; Robert G Miller; Stanley H Appel; Adriano Chiò
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

5.  Elevated C-Reactive Protein in Alzheimer's Disease Without Depression in Older Adults: Findings From the Health and Retirement Study.

Authors:  Ginny Natale; Sean A P Clouston; Dylan M Smith
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

6.  Association between levels of high-sensitivity C-reactive protein in plasma and freezing of gait in Parkinson's disease.

Authors:  Jie Liu; Weifang Yin; Chuanbin Zhou; Yangfan Zhu; Meijuan Gu; Bin Liu; Hui Ren; Xinglong Yang
Journal:  Aging Clin Exp Res       Date:  2022-04-26       Impact factor: 4.481

7.  Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging.

Authors:  Debjani Tripathy; Xiangling Yin; Alma Sanchez; Jinhua Luo; Joseph Martinez; Paula Grammas
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

8.  Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes.

Authors:  Pamela Maher; Richard Dargusch; Jennifer L Ehren; Shinichi Okada; Kumar Sharma; David Schubert
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

9.  Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.

Authors:  Atsushi Umemura; Tomoko Oeda; Kenji Yamamoto; Satoshi Tomita; Masayuki Kohsaka; Kwiyoung Park; Hiroshi Sugiyama; Hideyuki Sawada
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

10.  Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease.

Authors:  Hideyuki Sawada; Tomoko Oeda; Atsushi Umemura; Satoshi Tomita; Masayuki Kohsaka; Kwiyoung Park; Kenji Yamamoto; Hiroshi Sugiyama
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.